To determine how PAK1 enrichment had the ability to ameliorate mitochondrial dysfunction and structural damage mediated by insulin resistance in skeletal myotubes, we evaluated the mRNA and protein levels of PGC1α in these myotubes. The gene discussed is PAK1; the disease is Insulin resistance.